<!DOCTYPE html>
<!-- saved from url=(0014)about:internet -->
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<meta http-equiv="x-ua-compatible" content="IE=9" >

<title>ARID1a Expression in Upper Tract Urothelial Carcinoma</title>

<style type="text/css">
body, td {
   font-family: sans-serif;
   background-color: white;
   font-size: 12px;
   margin: 8px;
}

tt, code, pre {
   font-family: 'DejaVu Sans Mono', 'Droid Sans Mono', 'Lucida Console', Consolas, Monaco, monospace;
}

h1 { 
   font-size:2.2em; 
}

h2 { 
   font-size:1.8em; 
}

h3 { 
   font-size:1.4em; 
}

h4 { 
   font-size:1.0em; 
}

h5 { 
   font-size:0.9em; 
}

h6 { 
   font-size:0.8em; 
}

a:visited {
   color: rgb(50%, 0%, 50%);
}

pre {	
   margin-top: 0;
   max-width: 95%;
   border: 1px solid #ccc;
   white-space: pre-wrap;
}

pre code {
   display: block; padding: 0.5em;
}

code.r, code.cpp {
   background-color: #F8F8F8;
}

table, td, th {
  border: none;
}

blockquote {
   color:#666666;
   margin:0;
   padding-left: 1em;
   border-left: 0.5em #EEE solid;
}

hr {
   height: 0px;
   border-bottom: none;
   border-top-width: thin;
   border-top-style: dotted;
   border-top-color: #999999;
}

@media print {
   * { 
      background: transparent !important; 
      color: black !important; 
      filter:none !important; 
      -ms-filter: none !important; 
   }

   body { 
      font-size:12pt; 
      max-width:100%; 
   }
       
   a, a:visited { 
      text-decoration: underline; 
   }

   hr { 
      visibility: hidden;
      page-break-before: always;
   }

   pre, blockquote { 
      padding-right: 1em; 
      page-break-inside: avoid; 
   }

   tr, img { 
      page-break-inside: avoid; 
   }

   img { 
      max-width: 100% !important; 
   }

   @page :left { 
      margin: 15mm 20mm 15mm 10mm; 
   }
     
   @page :right { 
      margin: 15mm 10mm 15mm 20mm; 
   }

   p, h2, h3 { 
      orphans: 3; widows: 3; 
   }

   h2, h3 { 
      page-break-after: avoid; 
   }
}

</style>

<!-- Styles for R syntax highlighter -->
<style type="text/css">
   pre .operator,
   pre .paren {
     color: rgb(104, 118, 135)
   }

   pre .literal {
     color: rgb(88, 72, 246)
   }

   pre .number {
     color: rgb(0, 0, 205);
   }

   pre .comment {
     color: rgb(76, 136, 107);
   }

   pre .keyword {
     color: rgb(0, 0, 255);
   }

   pre .identifier {
     color: rgb(0, 0, 0);
   }

   pre .string {
     color: rgb(3, 106, 7);
   }
</style>

<!-- R syntax highlighter -->
<script type="text/javascript">
var hljs=new function(){function m(p){return p.replace(/&/gm,"&amp;").replace(/</gm,"&lt;")}function f(r,q,p){return RegExp(q,"m"+(r.cI?"i":"")+(p?"g":""))}function b(r){for(var p=0;p<r.childNodes.length;p++){var q=r.childNodes[p];if(q.nodeName=="CODE"){return q}if(!(q.nodeType==3&&q.nodeValue.match(/\s+/))){break}}}function h(t,s){var p="";for(var r=0;r<t.childNodes.length;r++){if(t.childNodes[r].nodeType==3){var q=t.childNodes[r].nodeValue;if(s){q=q.replace(/\n/g,"")}p+=q}else{if(t.childNodes[r].nodeName=="BR"){p+="\n"}else{p+=h(t.childNodes[r])}}}if(/MSIE [678]/.test(navigator.userAgent)){p=p.replace(/\r/g,"\n")}return p}function a(s){var r=s.className.split(/\s+/);r=r.concat(s.parentNode.className.split(/\s+/));for(var q=0;q<r.length;q++){var p=r[q].replace(/^language-/,"");if(e[p]){return p}}}function c(q){var p=[];(function(s,t){for(var r=0;r<s.childNodes.length;r++){if(s.childNodes[r].nodeType==3){t+=s.childNodes[r].nodeValue.length}else{if(s.childNodes[r].nodeName=="BR"){t+=1}else{if(s.childNodes[r].nodeType==1){p.push({event:"start",offset:t,node:s.childNodes[r]});t=arguments.callee(s.childNodes[r],t);p.push({event:"stop",offset:t,node:s.childNodes[r]})}}}}return t})(q,0);return p}function k(y,w,x){var q=0;var z="";var s=[];function u(){if(y.length&&w.length){if(y[0].offset!=w[0].offset){return(y[0].offset<w[0].offset)?y:w}else{return w[0].event=="start"?y:w}}else{return y.length?y:w}}function t(D){var A="<"+D.nodeName.toLowerCase();for(var B=0;B<D.attributes.length;B++){var C=D.attributes[B];A+=" "+C.nodeName.toLowerCase();if(C.value!==undefined&&C.value!==false&&C.value!==null){A+='="'+m(C.value)+'"'}}return A+">"}while(y.length||w.length){var v=u().splice(0,1)[0];z+=m(x.substr(q,v.offset-q));q=v.offset;if(v.event=="start"){z+=t(v.node);s.push(v.node)}else{if(v.event=="stop"){var p,r=s.length;do{r--;p=s[r];z+=("</"+p.nodeName.toLowerCase()+">")}while(p!=v.node);s.splice(r,1);while(r<s.length){z+=t(s[r]);r++}}}}return z+m(x.substr(q))}function j(){function q(x,y,v){if(x.compiled){return}var u;var s=[];if(x.k){x.lR=f(y,x.l||hljs.IR,true);for(var w in x.k){if(!x.k.hasOwnProperty(w)){continue}if(x.k[w] instanceof Object){u=x.k[w]}else{u=x.k;w="keyword"}for(var r in u){if(!u.hasOwnProperty(r)){continue}x.k[r]=[w,u[r]];s.push(r)}}}if(!v){if(x.bWK){x.b="\\b("+s.join("|")+")\\s"}x.bR=f(y,x.b?x.b:"\\B|\\b");if(!x.e&&!x.eW){x.e="\\B|\\b"}if(x.e){x.eR=f(y,x.e)}}if(x.i){x.iR=f(y,x.i)}if(x.r===undefined){x.r=1}if(!x.c){x.c=[]}x.compiled=true;for(var t=0;t<x.c.length;t++){if(x.c[t]=="self"){x.c[t]=x}q(x.c[t],y,false)}if(x.starts){q(x.starts,y,false)}}for(var p in e){if(!e.hasOwnProperty(p)){continue}q(e[p].dM,e[p],true)}}function d(B,C){if(!j.called){j();j.called=true}function q(r,M){for(var L=0;L<M.c.length;L++){if((M.c[L].bR.exec(r)||[null])[0]==r){return M.c[L]}}}function v(L,r){if(D[L].e&&D[L].eR.test(r)){return 1}if(D[L].eW){var M=v(L-1,r);return M?M+1:0}return 0}function w(r,L){return L.i&&L.iR.test(r)}function K(N,O){var M=[];for(var L=0;L<N.c.length;L++){M.push(N.c[L].b)}var r=D.length-1;do{if(D[r].e){M.push(D[r].e)}r--}while(D[r+1].eW);if(N.i){M.push(N.i)}return f(O,M.join("|"),true)}function p(M,L){var N=D[D.length-1];if(!N.t){N.t=K(N,E)}N.t.lastIndex=L;var r=N.t.exec(M);return r?[M.substr(L,r.index-L),r[0],false]:[M.substr(L),"",true]}function z(N,r){var L=E.cI?r[0].toLowerCase():r[0];var M=N.k[L];if(M&&M instanceof Array){return M}return false}function F(L,P){L=m(L);if(!P.k){return L}var r="";var O=0;P.lR.lastIndex=0;var M=P.lR.exec(L);while(M){r+=L.substr(O,M.index-O);var N=z(P,M);if(N){x+=N[1];r+='<span class="'+N[0]+'">'+M[0]+"</span>"}else{r+=M[0]}O=P.lR.lastIndex;M=P.lR.exec(L)}return r+L.substr(O,L.length-O)}function J(L,M){if(M.sL&&e[M.sL]){var r=d(M.sL,L);x+=r.keyword_count;return r.value}else{return F(L,M)}}function I(M,r){var L=M.cN?'<span class="'+M.cN+'">':"";if(M.rB){y+=L;M.buffer=""}else{if(M.eB){y+=m(r)+L;M.buffer=""}else{y+=L;M.buffer=r}}D.push(M);A+=M.r}function G(N,M,Q){var R=D[D.length-1];if(Q){y+=J(R.buffer+N,R);return false}var P=q(M,R);if(P){y+=J(R.buffer+N,R);I(P,M);return P.rB}var L=v(D.length-1,M);if(L){var O=R.cN?"</span>":"";if(R.rE){y+=J(R.buffer+N,R)+O}else{if(R.eE){y+=J(R.buffer+N,R)+O+m(M)}else{y+=J(R.buffer+N+M,R)+O}}while(L>1){O=D[D.length-2].cN?"</span>":"";y+=O;L--;D.length--}var r=D[D.length-1];D.length--;D[D.length-1].buffer="";if(r.starts){I(r.starts,"")}return R.rE}if(w(M,R)){throw"Illegal"}}var E=e[B];var D=[E.dM];var A=0;var x=0;var y="";try{var s,u=0;E.dM.buffer="";do{s=p(C,u);var t=G(s[0],s[1],s[2]);u+=s[0].length;if(!t){u+=s[1].length}}while(!s[2]);if(D.length>1){throw"Illegal"}return{r:A,keyword_count:x,value:y}}catch(H){if(H=="Illegal"){return{r:0,keyword_count:0,value:m(C)}}else{throw H}}}function g(t){var p={keyword_count:0,r:0,value:m(t)};var r=p;for(var q in e){if(!e.hasOwnProperty(q)){continue}var s=d(q,t);s.language=q;if(s.keyword_count+s.r>r.keyword_count+r.r){r=s}if(s.keyword_count+s.r>p.keyword_count+p.r){r=p;p=s}}if(r.language){p.second_best=r}return p}function i(r,q,p){if(q){r=r.replace(/^((<[^>]+>|\t)+)/gm,function(t,w,v,u){return w.replace(/\t/g,q)})}if(p){r=r.replace(/\n/g,"<br>")}return r}function n(t,w,r){var x=h(t,r);var v=a(t);var y,s;if(v){y=d(v,x)}else{return}var q=c(t);if(q.length){s=document.createElement("pre");s.innerHTML=y.value;y.value=k(q,c(s),x)}y.value=i(y.value,w,r);var u=t.className;if(!u.match("(\\s|^)(language-)?"+v+"(\\s|$)")){u=u?(u+" "+v):v}if(/MSIE [678]/.test(navigator.userAgent)&&t.tagName=="CODE"&&t.parentNode.tagName=="PRE"){s=t.parentNode;var p=document.createElement("div");p.innerHTML="<pre><code>"+y.value+"</code></pre>";t=p.firstChild.firstChild;p.firstChild.cN=s.cN;s.parentNode.replaceChild(p.firstChild,s)}else{t.innerHTML=y.value}t.className=u;t.result={language:v,kw:y.keyword_count,re:y.r};if(y.second_best){t.second_best={language:y.second_best.language,kw:y.second_best.keyword_count,re:y.second_best.r}}}function o(){if(o.called){return}o.called=true;var r=document.getElementsByTagName("pre");for(var p=0;p<r.length;p++){var q=b(r[p]);if(q){n(q,hljs.tabReplace)}}}function l(){if(window.addEventListener){window.addEventListener("DOMContentLoaded",o,false);window.addEventListener("load",o,false)}else{if(window.attachEvent){window.attachEvent("onload",o)}else{window.onload=o}}}var e={};this.LANGUAGES=e;this.highlight=d;this.highlightAuto=g;this.fixMarkup=i;this.highlightBlock=n;this.initHighlighting=o;this.initHighlightingOnLoad=l;this.IR="[a-zA-Z][a-zA-Z0-9_]*";this.UIR="[a-zA-Z_][a-zA-Z0-9_]*";this.NR="\\b\\d+(\\.\\d+)?";this.CNR="\\b(0[xX][a-fA-F0-9]+|(\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)";this.BNR="\\b(0b[01]+)";this.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|\\.|-|-=|/|/=|:|;|<|<<|<<=|<=|=|==|===|>|>=|>>|>>=|>>>|>>>=|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~";this.ER="(?![\\s\\S])";this.BE={b:"\\\\.",r:0};this.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[this.BE],r:0};this.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[this.BE],r:0};this.CLCM={cN:"comment",b:"//",e:"$"};this.CBLCLM={cN:"comment",b:"/\\*",e:"\\*/"};this.HCM={cN:"comment",b:"#",e:"$"};this.NM={cN:"number",b:this.NR,r:0};this.CNM={cN:"number",b:this.CNR,r:0};this.BNM={cN:"number",b:this.BNR,r:0};this.inherit=function(r,s){var p={};for(var q in r){p[q]=r[q]}if(s){for(var q in s){p[q]=s[q]}}return p}}();hljs.LANGUAGES.cpp=function(){var a={keyword:{"false":1,"int":1,"float":1,"while":1,"private":1,"char":1,"catch":1,"export":1,virtual:1,operator:2,sizeof:2,dynamic_cast:2,typedef:2,const_cast:2,"const":1,struct:1,"for":1,static_cast:2,union:1,namespace:1,unsigned:1,"long":1,"throw":1,"volatile":2,"static":1,"protected":1,bool:1,template:1,mutable:1,"if":1,"public":1,friend:2,"do":1,"return":1,"goto":1,auto:1,"void":2,"enum":1,"else":1,"break":1,"new":1,extern:1,using:1,"true":1,"class":1,asm:1,"case":1,typeid:1,"short":1,reinterpret_cast:2,"default":1,"double":1,register:1,explicit:1,signed:1,typename:1,"try":1,"this":1,"switch":1,"continue":1,wchar_t:1,inline:1,"delete":1,alignof:1,char16_t:1,char32_t:1,constexpr:1,decltype:1,noexcept:1,nullptr:1,static_assert:1,thread_local:1,restrict:1,_Bool:1,complex:1},built_in:{std:1,string:1,cin:1,cout:1,cerr:1,clog:1,stringstream:1,istringstream:1,ostringstream:1,auto_ptr:1,deque:1,list:1,queue:1,stack:1,vector:1,map:1,set:1,bitset:1,multiset:1,multimap:1,unordered_set:1,unordered_map:1,unordered_multiset:1,unordered_multimap:1,array:1,shared_ptr:1}};return{dM:{k:a,i:"</",c:[hljs.CLCM,hljs.CBLCLM,hljs.QSM,{cN:"string",b:"'\\\\?.",e:"'",i:"."},{cN:"number",b:"\\b(\\d+(\\.\\d*)?|\\.\\d+)(u|U|l|L|ul|UL|f|F)"},hljs.CNM,{cN:"preprocessor",b:"#",e:"$"},{cN:"stl_container",b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:a,r:10,c:["self"]}]}}}();hljs.LANGUAGES.r={dM:{c:[hljs.HCM,{cN:"number",b:"\\b0[xX][0-9a-fA-F]+[Li]?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+(?:[eE][+\\-]?\\d*)?L\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+\\.(?!\\d)(?:i\\b)?",e:hljs.IMMEDIATE_RE,r:1},{cN:"number",b:"\\b\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"keyword",b:"(?:tryCatch|library|setGeneric|setGroupGeneric)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\.",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\d+(?![\\w.])",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\b(?:function)",e:hljs.IMMEDIATE_RE,r:2},{cN:"keyword",b:"(?:if|in|break|next|repeat|else|for|return|switch|while|try|stop|warning|require|attach|detach|source|setMethod|setClass)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"literal",b:"(?:NA|NA_integer_|NA_real_|NA_character_|NA_complex_)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"literal",b:"(?:NULL|TRUE|FALSE|T|F|Inf|NaN)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"identifier",b:"[a-zA-Z.][a-zA-Z0-9._]*\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"<\\-(?!\\s*\\d)",e:hljs.IMMEDIATE_RE,r:2},{cN:"operator",b:"\\->|<\\-",e:hljs.IMMEDIATE_RE,r:1},{cN:"operator",b:"%%|~",e:hljs.IMMEDIATE_RE},{cN:"operator",b:">=|<=|==|!=|\\|\\||&&|=|\\+|\\-|\\*|/|\\^|>|<|!|&|\\||\\$|:",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"%",e:"%",i:"\\n",r:1},{cN:"identifier",b:"`",e:"`",r:0},{cN:"string",b:'"',e:'"',c:[hljs.BE],r:0},{cN:"string",b:"'",e:"'",c:[hljs.BE],r:0},{cN:"paren",b:"[[({\\])}]",e:hljs.IMMEDIATE_RE,r:0}]}};
hljs.initHighlightingOnLoad();
</script>




</head>

<body>
<h1>ARID1a Expression in Upper Tract Urothelial Carcinoma</h1>

<p>Last update: <code>Mon May 19 21:18:31 2014</code></p>

<pre><code class="r">opts_chunk$set(echo = FALSE, warning = FALSE, message = FALSE)
</code></pre>

<ul>
<li>Loading the libraries and functions required for the analysis</li>
</ul>

<pre><code class="r">library(survival)
source(file = &quot;../standard.analysis.R&quot;)
</code></pre>

<ul>
<li>Opening the dataset, selecting variables relevant to the analysis, and dropping unused levels</li>
</ul>

<pre><code class="r">arid1a.full &lt;- read.csv(file = &quot;../arid1a.utuc.csv&quot;)
arid1a.data &lt;- arid1a.full[c(&quot;sex&quot;, &quot;age&quot;, &quot;location&quot;, &quot;location2&quot;, &quot;pT&quot;, &quot;pT.2&quot;, 
    &quot;pT.a&quot;, &quot;WHO.grade&quot;, &quot;lymph.nodes&quot;, &quot;lvi&quot;, &quot;metastasis&quot;, &quot;bladder.recur&quot;, 
    &quot;fu.recur&quot;, &quot;tumor.prog&quot;, &quot;fu.prog&quot;, &quot;outcome&quot;, &quot;dod&quot;, &quot;fu.outcome&quot;, &quot;tumor.h.med&quot;, 
    &quot;tumor.pos.med&quot;, &quot;normal.h.med&quot;, &quot;normal.pos.med&quot;, &quot;tumor.h.0&quot;, &quot;tumor.h.p50&quot;, 
    &quot;tumor.h.q3&quot;, &quot;tumor.pos.0&quot;, &quot;tumor.pos.p50&quot;, &quot;tumor.pos.q3&quot;)]
arid1a.data &lt;- droplevels(arid1a.data)
</code></pre>

<hr/>

<h2>1) Clinicopathologic Features and Outcome</h2>

<ul>
<li>Patient&#39;s age</li>
</ul>

<pre><code>##        Values
## Mean     70.0
## SD        8.9
## Median   71.0
## IQR      11.5
</code></pre>

<ul>
<li>Patient&#39;s sex</li>
</ul>

<pre><code>##        Count Percentages
## Female    39        39.4
## Male      60        60.6
</code></pre>

<ul>
<li>Tumor location</li>
</ul>

<pre><code>##               Count Percentages
## Pelvis           45        45.5
## Pelvis-Ureter     4         4.0
## Ureter           50        50.5
</code></pre>

<ul>
<li>pT stage</li>
</ul>

<pre><code>##     Count Percentages
## pT1    18        18.2
## pT2     8         8.1
## pT3    48        48.5
## pT4     6         6.1
## pTa    19        19.2
</code></pre>

<ul>
<li>WHO histologic grade</li>
</ul>

<pre><code>##            Count Percentages
## High Grade    84        84.8
## Low Grade     15        15.2
</code></pre>

<ul>
<li>Lymphovascular invasion</li>
</ul>

<pre><code>##     Count Percentages
## No     59        59.6
## Yes    40        40.4
</code></pre>

<ul>
<li>Lymph node metastasis</li>
</ul>

<pre><code>##      Count Percentages
## No      84        84.8
## Yes     12        12.1
## &lt;NA&gt;     3         3.0
</code></pre>

<ul>
<li>Distant metastasis</li>
</ul>

<pre><code>##      Count Percentages
## No      90        90.9
## Yes      4         4.0
## &lt;NA&gt;     5         5.1
</code></pre>

<ul>
<li>Bladder recurrence</li>
</ul>

<pre><code>##      Count Percentages
## No      65        65.7
## Yes     32        32.3
## &lt;NA&gt;     2         2.0
</code></pre>

<ul>
<li>tumor progression</li>
</ul>

<pre><code>##     Count Percentages
## No     61        61.6
## Yes    38        38.4
</code></pre>

<ul>
<li>Patient&#39;s outcome</li>
</ul>

<pre><code>##     Count Percentages
## AWD     5         5.1
## DOC     3         3.0
## DOD    30        30.3
## LFU    23        23.2
## NED    38        38.4
</code></pre>

<hr/>

<h2>2) Association of Clinicopathologic Features and ARID1a Expression with Tumor Progression</h2>

<ul>
<li>Cases with tumor progression</li>
</ul>

<pre><code>## 
##  No Yes 
##  61  38
</code></pre>

<ul>
<li>Patient&#39;s age</li>
</ul>

<pre><code>##        No Yes
## Median 71  72
## IQR    15  12
## 
## Mann-Whitney&#39;s P value = 0.1467
</code></pre>

<ul>
<li>Patient&#39;s sex</li>
</ul>

<pre><code>## **Table of Frequencies**
##         Column
## Row      No Yes
##   Female 26  13
##   Male   35  25
## 
## **Row Percentages**
##         Column
## Row      No Yes
##   Female 67  33
##   Male   58  42
## 
## **Column Percentages**
##         Column
## Row      No Yes
##   Female 43  34
##   Male   57  66
## 
## Fisher&#39;s P value = 0.5262
</code></pre>

<ul>
<li>Tumor location</li>
</ul>

<pre><code>## **Table of Frequencies**
##                Column
## Row             No Yes
##   Pelvis        30  15
##   Pelvis-Ureter  2   2
##   Ureter        29  21
## 
## **Row Percentages**
##                Column
## Row             No Yes
##   Pelvis        67  33
##   Pelvis-Ureter 50  50
##   Ureter        58  42
## 
## **Column Percentages**
##                Column
## Row             No Yes
##   Pelvis        49  39
##   Pelvis-Ureter  3   5
##   Ureter        48  55
## 
## Fisher&#39;s P value = 0.5787
</code></pre>

<ul>
<li>pT stage</li>
</ul>

<pre><code>## **Table of Frequencies**
##      Column
## Row   No Yes
##   pT1 17   1
##   pT2  6   2
##   pT3 19  29
##   pT4  1   5
##   pTa 18   1
## 
## **Row Percentages**
##      Column
## Row   No Yes
##   pT1 94   6
##   pT2 75  25
##   pT3 40  60
##   pT4 17  83
##   pTa 95   5
## 
## **Column Percentages**
##      Column
## Row   No Yes
##   pT1 28   3
##   pT2 10   5
##   pT3 31  76
##   pT4  2  13
##   pTa 30   3
## 
## Fisher&#39;s P value = 1.278e-07
</code></pre>

<ul>
<li>WHO histologic grade</li>
</ul>

<pre><code>## **Table of Frequencies**
##             Column
## Row          No Yes
##   High Grade 48  36
##   Low Grade  13   2
## 
## **Row Percentages**
##             Column
## Row          No Yes
##   High Grade 57  43
##   Low Grade  87  13
## 
## **Column Percentages**
##             Column
## Row          No Yes
##   High Grade 79  95
##   Low Grade  21   5
## 
## Fisher&#39;s P value = 0.04221
</code></pre>

<ul>
<li>Lymph node metastasis</li>
</ul>

<pre><code>## **Table of Frequencies**
##      Column
## Row   No Yes
##   No  55  29
##   Yes  3   9
## 
## **Row Percentages**
##      Column
## Row   No Yes
##   No  65  35
##   Yes 25  75
## 
## **Column Percentages**
##      Column
## Row   No Yes
##   No  95  76
##   Yes  5  24
## 
## Fisher&#39;s P value = 0.01085
</code></pre>

<ul>
<li>Lymmphovascular invasion</li>
</ul>

<pre><code>## **Table of Frequencies**
##      Column
## Row   No Yes
##   No  48  11
##   Yes 13  27
## 
## **Row Percentages**
##      Column
## Row   No Yes
##   No  81  19
##   Yes 32  68
## 
## **Column Percentages**
##      Column
## Row   No Yes
##   No  79  29
##   Yes 21  71
## 
## Fisher&#39;s P value = 1.918e-06
</code></pre>

<ul>
<li>Tumor median H-score</li>
</ul>

<pre><code>##           No   Yes
## Median 160.0 170.0
## IQR    207.5 214.4
## 
## Mann-Whitney&#39;s P value = 0.6049
</code></pre>

<ul>
<li>Tumor median % positive cells</li>
</ul>

<pre><code>##          No  Yes
## Median 90.0 75.0
## IQR    41.9 48.8
## 
## Mann-Whitney&#39;s P value = 0.9046
</code></pre>

<hr/>

<h2>3) Association of Clinicopathologic Features and ARID1a Expression with Cancer-Related mortality</h2>

<ul>
<li>Cases with cancer-related mortality</li>
</ul>

<pre><code>## 
##  No Yes 
##  69  30
</code></pre>

<ul>
<li>Patient&#39;s age</li>
</ul>

<pre><code>##        No  Yes
## Median 71 71.5
## IQR    14 10.5
## 
## Mann-Whitney&#39;s P value = 0.4832
</code></pre>

<ul>
<li>Patient&#39;s sex</li>
</ul>

<pre><code>## **Table of Frequencies**
##         Column
## Row      No Yes
##   Female 29  10
##   Male   40  20
## 
## **Row Percentages**
##         Column
## Row      No Yes
##   Female 74  26
##   Male   67  33
## 
## **Column Percentages**
##         Column
## Row      No Yes
##   Female 42  33
##   Male   58  67
## 
## Fisher&#39;s P value = 0.5044
</code></pre>

<ul>
<li>Tumor location</li>
</ul>

<pre><code>## **Table of Frequencies**
##                Column
## Row             No Yes
##   Pelvis        32  13
##   Pelvis-Ureter  3   1
##   Ureter        34  16
## 
## **Row Percentages**
##                Column
## Row             No Yes
##   Pelvis        71  29
##   Pelvis-Ureter 75  25
##   Ureter        68  32
## 
## **Column Percentages**
##                Column
## Row             No Yes
##   Pelvis        46  43
##   Pelvis-Ureter  4   3
##   Ureter        49  53
## 
## Fisher&#39;s P value = 0.9269
</code></pre>

<ul>
<li>pT stage</li>
</ul>

<pre><code>## **Table of Frequencies**
##      Column
## Row   No Yes
##   pT1 18   0
##   pT2  6   2
##   pT3 25  23
##   pT4  1   5
##   pTa 19   0
## 
## **Row Percentages**
##      Column
## Row    No Yes
##   pT1 100   0
##   pT2  75  25
##   pT3  52  48
##   pT4  17  83
##   pTa 100   0
## 
## **Column Percentages**
##      Column
## Row   No Yes
##   pT1 26   0
##   pT2  9   7
##   pT3 36  77
##   pT4  1  17
##   pTa 28   0
## 
## Fisher&#39;s P value = 1.284e-07
</code></pre>

<ul>
<li>WHO histologic grade</li>
</ul>

<pre><code>## **Table of Frequencies**
##             Column
## Row          No Yes
##   High Grade 55  29
##   Low Grade  14   1
## 
## **Row Percentages**
##             Column
## Row          No Yes
##   High Grade 65  35
##   Low Grade  93   7
## 
## **Column Percentages**
##             Column
## Row          No Yes
##   High Grade 80  97
##   Low Grade  20   3
## 
## Fisher&#39;s P value = 0.03395
</code></pre>

<ul>
<li>Lymph node metastasis</li>
</ul>

<pre><code>## **Table of Frequencies**
##      Column
## Row   No Yes
##   No  61  23
##   Yes  5   7
## 
## **Row Percentages**
##      Column
## Row   No Yes
##   No  73  27
##   Yes 42  58
## 
## **Column Percentages**
##      Column
## Row   No Yes
##   No  92  77
##   Yes  8  23
## 
## Fisher&#39;s P value = 0.04492
</code></pre>

<ul>
<li>Lymphovascular invasion</li>
</ul>

<pre><code>## **Table of Frequencies**
##      Column
## Row   No Yes
##   No  51   8
##   Yes 18  22
## 
## **Row Percentages**
##      Column
## Row   No Yes
##   No  86  14
##   Yes 45  55
## 
## **Column Percentages**
##      Column
## Row   No Yes
##   No  74  27
##   Yes 26  73
## 
## Fisher&#39;s P value = 1.606e-05
</code></pre>

<ul>
<li>Tumor median H-score</li>
</ul>

<pre><code>##           No Yes
## Median 177.5 130
## IQR    205.0 215
## 
## Mann-Whitney&#39;s P value = 0.8966
</code></pre>

<ul>
<li>Tumor median % positive cells</li>
</ul>

<pre><code>##        No Yes
## Median 90  75
## IQR    35  55
## 
## Mann-Whitney&#39;s P value = 0.3724
</code></pre>

<hr/>

<h2>4) Odds Ratios for Tumor Progression</h2>

<h3>4.1) Clinicopathologic features</h3>

<ul>
<li>Patient&#39;s age</li>
</ul>

<pre><code>##             Odds Ratio     2.5 % 97.5 % P value
## (Intercept)    0.02869 0.0007659 0.8003 0.04342
## age            1.04470 0.9967841 1.0987 0.07600
</code></pre>

<ul>
<li>Patient&#39;s sex</li>
</ul>

<pre><code>##             Odds Ratio  2.5 % 97.5 % P value
## (Intercept)      0.500 0.2490 0.9551 0.04129
## sexMale          1.429 0.6216 3.3694 0.40563
</code></pre>

<ul>
<li>Tumor location (Pelvis vs. ureter, tumors in pelvis-ureter excluded)</li>
</ul>

<pre><code>##                 Odds Ratio  2.5 % 97.5 % P value
## (Intercept)          0.500 0.2619 0.9142 0.02838
## location2Ureter      1.448 0.6302 3.3824 0.38543
</code></pre>

<ul>
<li>High pT stage (&gt;pT2)</li>
</ul>

<pre><code>##             Odds Ratio   2.5 %  97.5 %   P value
## (Intercept)    0.09756 0.02931  0.2415 8.877e-06
## pT.2Yes       17.42500 5.96830 64.5689 1.550e-06
</code></pre>

<ul>
<li>WHO histologic grade</li>
</ul>

<pre><code>##                    Odds Ratio   2.5 % 97.5 % P value
## (Intercept)            0.7500 0.48385 1.1522 0.19196
## WHO.gradeLow Grade     0.2051 0.03083 0.8036 0.04519
</code></pre>

<ul>
<li>Metastatic lymph nodes</li>
</ul>

<pre><code>##                Odds Ratio  2.5 %  97.5 %  P value
## (Intercept)        0.5273 0.3321  0.8197 0.005287
## lymph.nodesYes     5.6897 1.5620 27.1552 0.013665
</code></pre>

<ul>
<li>Lymphovascular invasion</li>
</ul>

<pre><code>##             Odds Ratio 2.5 %  97.5 %   P value
## (Intercept)     0.2292 0.113  0.4245 1.046e-05
## lviYes          9.0629 3.683 23.9370 3.491e-06
</code></pre>

<h3>4.2) ARID1a Expression, Unadjusted</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##              Odds Ratio  2.5 % 97.5 % P value
## (Intercept)       0.625 0.4062 0.9484 0.02916
## tumor.h.0Low      0.960 0.1876 4.1610 0.95724
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##                Odds Ratio  2.5 % 97.5 % P value
## (Intercept)        0.6857 0.4033  1.146  0.1546
## tumor.h.p50Low     0.7853 0.3371  1.794  0.5690
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile </li>
</ul>

<pre><code>##               Odds Ratio  2.5 % 97.5 % P value
## (Intercept)       0.8095 0.4217  1.532  0.5172
## tumor.h.q3Low     0.6485 0.2815  1.489  0.3061
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##                Odds Ratio  2.5 % 97.5 % P value
## (Intercept)         0.625 0.4062 0.9484 0.02916
## tumor.pos.0Low      0.960 0.1876 4.1610 0.95724
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##                  Odds Ratio  2.5 % 97.5 % P value
## (Intercept)          0.5128 0.2935 0.8684 0.01517
## tumor.pos.p50Low     1.5955 0.6997 3.6594 0.26636
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##                 Odds Ratio  2.5 % 97.5 % P value
## (Intercept)         0.9375 0.4589  1.905  0.8575
## tumor.pos.q3Low     0.5452 0.2278  1.298  0.1694
</code></pre>

<h3>4.3) ARID1a, Adjusted by Clinicopathologic Features</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 % 97.5 %   P value
## (Intercept)          0.007639 3.856e-05  0.874 0.0538022
## tumor.h.0Low         1.439069 1.942e-01  9.914 0.7111554
## age                  1.050128 9.855e-01  1.125 0.1424902
## sexMale              1.335766 4.369e-01  4.124 0.6092737
## location2Ureter      0.897654 3.113e-01  2.519 0.8379501
## WHO.gradeLow Grade   0.266703 3.549e-02  1.280 0.1317755
## lymph.nodesYes       1.454770 2.988e-01  8.545 0.6533197
## lviYes               8.285272 2.749e+00 27.652 0.0002914
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 % 97.5 %  P value
## (Intercept)          0.007886 0.0000346  1.024 0.062108
## tumor.h.p50Low       1.134845 0.3736342  3.538 0.823595
## age                  1.049200 0.9845620  1.124 0.149983
## sexMale              1.322892 0.4257580  4.167 0.626762
## location2Ureter      0.923910 0.3189102  2.615 0.881561
## WHO.gradeLow Grade   0.260470 0.0348126  1.248 0.123974
## lymph.nodesYes       1.497655 0.3018714  9.016 0.633235
## lviYes               8.284122 2.7517179 27.620 0.000288
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile </li>
</ul>

<pre><code>##                    Odds Ratio     2.5 % 97.5 %   P value
## (Intercept)          0.009403 4.773e-05  1.107 0.0654939
## tumor.h.q3Low        1.011825 3.569e-01  2.979 0.9825029
## age                  1.047633 9.841e-01  1.121 0.1553587
## sexMale              1.278045 4.276e-01  3.844 0.6579713
## location2Ureter      0.910790 3.165e-01  2.556 0.8593729
## WHO.gradeLow Grade   0.261580 3.452e-02  1.260 0.1276803
## lymph.nodesYes       1.456800 2.984e-01  8.582 0.6526140
## lviYes               8.332791 2.734e+00 28.303 0.0003301
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 % 97.5 %   P value
## (Intercept)          0.007639 3.856e-05  0.874 0.0538022
## tumor.pos.0Low       1.439069 1.942e-01  9.914 0.7111554
## age                  1.050128 9.855e-01  1.125 0.1424902
## sexMale              1.335766 4.369e-01  4.124 0.6092737
## location2Ureter      0.897654 3.113e-01  2.519 0.8379501
## WHO.gradeLow Grade   0.266703 3.549e-02  1.280 0.1317755
## lymph.nodesYes       1.454770 2.988e-01  8.545 0.6533197
## lviYes               8.285272 2.749e+00 27.652 0.0002914
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 % 97.5 %   P value
## (Intercept)          0.006136 0.0000305  0.694 0.0439484
## tumor.pos.p50Low     1.781043 0.6213340  5.280 0.2852497
## age                  1.049040 0.9847783  1.123 0.1482021
## sexMale              1.420001 0.4639522  4.441 0.5381077
## location2Ureter      0.971755 0.3337001  2.779 0.9572828
## WHO.gradeLow Grade   0.264178 0.0356210  1.247 0.1252252
## lymph.nodesYes       1.592987 0.3183800  9.666 0.5839700
## lviYes               8.104273 2.6671676 27.326 0.0003737
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 % 97.5 %   P value
## (Intercept)           0.01331 7.641e-05  1.435 0.0815116
## tumor.pos.q3Low       0.65127 2.159e-01  1.954 0.4407403
## age                   1.04790 9.846e-01  1.121 0.1516121
## sexMale               1.18970 3.917e-01  3.606 0.7564883
## location2Ureter       0.89182 3.087e-01  2.506 0.8285784
## WHO.gradeLow Grade    0.25224 3.319e-02  1.231 0.1194989
## lymph.nodesYes        1.47173 3.008e-01  8.727 0.6447172
## lviYes                8.06320 2.674e+00 26.881 0.0003472
</code></pre>

<hr/>

<h2>5) Odds Ratios for Cancer-Specific Mortality</h2>

<h3>5.1) Clinicopathologic features</h3>

<ul>
<li>Patient&#39;s age</li>
</ul>

<pre><code>##             Odds Ratio    2.5 % 97.5 % P value
## (Intercept)    0.07205 0.001749  2.236  0.1457
## age            1.02587 0.977133  1.080  0.3138
</code></pre>

<ul>
<li>Patient&#39;s sex</li>
</ul>

<pre><code>##             Odds Ratio  2.5 % 97.5 %  P value
## (Intercept)     0.3448 0.1597 0.6838 0.003692
## sexMale         1.4500 0.6002 3.6591 0.416895
</code></pre>

<ul>
<li>Tumor location (Pelvis vs. ureter, tumors in pelvis-ureter excluded)</li>
</ul>

<pre><code>##                 Odds Ratio  2.5 % 97.5 %  P value
## (Intercept)         0.4063 0.2058 0.7559 0.006166
## location2Ureter     1.1584 0.4825 2.8158 0.742409
</code></pre>

<ul>
<li>High pT stage (&gt;pT2)</li>
</ul>

<pre><code>##             Odds Ratio    2.5 %   97.5 %   P value
## (Intercept)    0.04651 0.007585   0.1507 2.216e-05
## pT.2Yes       23.15385 6.254961 150.9528 4.789e-05
</code></pre>

<ul>
<li>WHO histologic grade</li>
</ul>

<pre><code>##                    Odds Ratio    2.5 % 97.5 %  P value
## (Intercept)            0.5273 0.332109 0.8197 0.005287
## WHO.gradeLow Grade     0.1355 0.007295 0.7263 0.059368
</code></pre>

<ul>
<li>Metastatic lymph nodes</li>
</ul>

<pre><code>##                Odds Ratio  2.5 % 97.5 %   P value
## (Intercept)         0.377 0.2288   0.60 6.713e-05
## lymph.nodesYes      3.713 1.0803  13.69 3.872e-02
</code></pre>

<ul>
<li>Lymphovascular invasion</li>
</ul>

<pre><code>##             Odds Ratio   2.5 %  97.5 %   P value
## (Intercept)     0.1569 0.06881  0.3118 1.109e-06
## lviYes          7.7917 3.05544 21.6583 3.434e-05
</code></pre>

<h3>5.2) ARID1a Expression, Unadjusted</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##              Odds Ratio  2.5 % 97.5 %   P value
## (Intercept)      0.4219 0.2648 0.6537 0.0001693
## tumor.h.0Low     1.4222 0.2762 6.2186 0.6454327
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##                Odds Ratio  2.5 % 97.5 %  P value
## (Intercept)        0.4048 0.2244 0.6979 0.001653
## tumor.h.p50Low     1.1895 0.4935 2.8354 0.695457
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile </li>
</ul>

<pre><code>##               Odds Ratio  2.5 % 97.5 % P value
## (Intercept)       0.4615 0.2246 0.8947 0.02673
## tumor.h.q3Low     0.9070 0.3785 2.2155 0.82743
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##                Odds Ratio  2.5 % 97.5 %   P value
## (Intercept)        0.4219 0.2648 0.6537 0.0001693
## tumor.pos.0Low     1.4222 0.2762 6.2186 0.6454327
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##                  Odds Ratio  2.5 % 97.5 %  P value
## (Intercept)          0.3111 0.1646 0.5517 0.000136
## tumor.pos.p50Low     2.1429 0.8989 5.1894 0.086607
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##                 Odds Ratio  2.5 % 97.5 % P value
## (Intercept)         0.4091 0.1786 0.8602 0.02389
## tumor.pos.q3Low     1.0922 0.4379 2.8628 0.85265
</code></pre>

<h3>5.3) ARID1a, Adjusted by Clinicopathologic Features</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 %  97.5 %   P value
## (Intercept)           0.04164 0.0002545  4.6585 0.1987993
## tumor.h.0Low          2.01861 0.2942030 13.1335 0.4567157
## age                   1.02455 0.9608368  1.0956 0.4633663
## sexMale               1.10019 0.3557178  3.4207 0.8671130
## location2Ureter       0.70071 0.2394248  1.9739 0.5043414
## WHO.gradeLow Grade    0.15814 0.0080692  0.9741 0.0969118
## lymph.nodesYes        0.92555 0.2049263  4.3033 0.9193362
## lviYes                7.20248 2.3357684 24.4680 0.0008835
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 %  97.5 %   P value
## (Intercept)            0.0221 0.0001037  2.8733 0.1389174
## tumor.h.p50Low         2.1426 0.7041677  6.9912 0.1877762
## age                    1.0279 0.9636216  1.1002 0.4102861
## sexMale                1.2562 0.3954689  4.0825 0.6982157
## location2Ureter        0.7778 0.2640863  2.2291 0.6406349
## WHO.gradeLow Grade     0.1475 0.0075230  0.9031 0.0847643
## lymph.nodesYes         1.0533 0.2257992  5.1659 0.9472811
## lviYes                 7.3175 2.3472456 25.3428 0.0009275
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile </li>
</ul>

<pre><code>##                    Odds Ratio     2.5 %  97.5 %   P value
## (Intercept)           0.03823 0.0002355  4.2801 0.1866181
## tumor.h.q3Low         1.60155 0.5583690  4.9122 0.3914633
## age                   1.02182 0.9591761  1.0913 0.5066836
## sexMale               1.05311 0.3459167  3.2084 0.9265854
## location2Ureter       0.74304 0.2546467  2.1015 0.5772414
## WHO.gradeLow Grade    0.16160 0.0082580  0.9867 0.1002438
## lymph.nodesYes        0.89758 0.1951268  4.2440 0.8887560
## lviYes                7.93632 2.5218052 27.9582 0.0006526
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 %  97.5 %   P value
## (Intercept)           0.04164 0.0002545  4.6585 0.1987993
## tumor.pos.0Low        2.01861 0.2942030 13.1335 0.4567157
## age                   1.02455 0.9608368  1.0956 0.4633663
## sexMale               1.10019 0.3557178  3.4207 0.8671130
## location2Ureter       0.70071 0.2394248  1.9739 0.5043414
## WHO.gradeLow Grade    0.15814 0.0080692  0.9741 0.0969118
## lymph.nodesYes        0.92555 0.2049263  4.3033 0.9193362
## lviYes                7.20248 2.3357684 24.4680 0.0008835
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##                    Odds Ratio     2.5 %  97.5 %  P value
## (Intercept)           0.03379 0.0001915  3.8782 0.174906
## tumor.pos.p50Low      2.85288 0.9847531  8.8080 0.057909
## age                   1.01934 0.9551437  1.0903 0.565438
## sexMale               1.26108 0.3991629  4.0879 0.692242
## location2Ureter       0.81181 0.2717190  2.3732 0.702925
## WHO.gradeLow Grade    0.14877 0.0074525  0.9306 0.089777
## lymph.nodesYes        1.04821 0.2203688  5.2073 0.952720
## lviYes                7.05031 2.2413392 24.5799 0.001245
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##                    Odds Ratio    2.5 %  97.5 %   P value
## (Intercept)           0.03986 0.000266  4.2015 0.1861614
## tumor.pos.q3Low       1.91224 0.628173  6.3381 0.2671882
## age                   1.01836 0.955750  1.0872 0.5751161
## sexMale               1.09411 0.357447  3.3618 0.8735536
## location2Ureter       0.74928 0.255730  2.1290 0.5894885
## WHO.gradeLow Grade    0.15574 0.007922  0.9649 0.0949885
## lymph.nodesYes        0.92353 0.201696  4.3619 0.9178776
## lviYes                7.99500 2.537990 28.2632 0.0006379
</code></pre>

<hr/>

<h2>6) Hazard Ratios for Tumor Progression</h2>

<h3>6.1) Clinicopathologic features</h3>

<ul>
<li>Patient&#39;s age</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.035       0.9972        1.075 0.06999
</code></pre>

<ul>
<li>Patient&#39;s sex</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.343       0.6867        2.627  0.3888
</code></pre>

<ul>
<li>Tumor location (Pelvis vs. ureter, tumors in pelvis-ureter excluded)</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.254       0.6454        2.435  0.5044
</code></pre>

<ul>
<li>High pT stage (&gt;pT2)</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI   P value
## [1,]        11.39        4.019        32.26 4.698e-06
</code></pre>

<ul>
<li>WHO histologic grade</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.2224      0.05339       0.9262  0.0389
</code></pre>

<ul>
<li>Metastatic lymph nodes</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI   P value
## [1,]        4.517        2.123        9.614 9.118e-05
</code></pre>

<ul>
<li>Lymphovascular invasion</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI   P value
## [1,]        5.996        2.958        12.15 6.727e-07
</code></pre>

<h3>6.2) ARID1a Unadjusted</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.9056       0.2784        2.945  0.8691
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.7166       0.3699        1.388  0.3234
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.6981       0.3681        1.324   0.271
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.9056       0.2784        2.945  0.8691
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.299       0.6863        2.457  0.4218
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.5839       0.3042        1.121   0.106
</code></pre>

<h3>6.3) ARID1a, Adjusted by Clinicopathologic Features</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.h.0Low             1.2015      0.32486        4.444 0.7832681
## age                      1.0285      0.98409        1.075 0.2120304
## sexMale                  0.9256      0.42965        1.994 0.8434167
## location2Ureter          0.7148      0.35683        1.432 0.3436116
## WHO.gradeLow Grade       0.2685      0.06233        1.156 0.0775655
## lymph.nodesYes           1.9265      0.81618        4.547 0.1345425
## lviYes                   5.3084      2.28796       12.316 0.0001013
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.h.p50Low           0.8757      0.42983        1.784 0.7146662
## age                      1.0254      0.98258        1.070 0.2489355
## sexMale                  0.8699      0.40391        1.873 0.7217467
## location2Ureter          0.7132      0.35674        1.426 0.3389409
## WHO.gradeLow Grade       0.2609      0.06071        1.121 0.0708727
## lymph.nodesYes           1.9338      0.82182        4.550 0.1309137
## lviYes                   5.3456      2.29723       12.439 0.0001002
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.h.q3Low            1.1050      0.56061        2.178 7.730e-01
## age                      1.0271      0.98471        1.071 2.134e-01
## sexMale                  0.9140      0.43401        1.925 8.128e-01
## location2Ureter          0.7217      0.36110        1.443 3.560e-01
## WHO.gradeLow Grade       0.2678      0.06229        1.152 7.669e-02
## lymph.nodesYes           1.9524      0.83210        4.581 1.242e-01
## lviYes                   5.3753      2.31381       12.488 9.208e-05
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.pos.0Low           1.2015      0.32486        4.444 0.7832681
## age                      1.0285      0.98409        1.075 0.2120304
## sexMale                  0.9256      0.42965        1.994 0.8434167
## location2Ureter          0.7148      0.35683        1.432 0.3436116
## WHO.gradeLow Grade       0.2685      0.06233        1.156 0.0775655
## lymph.nodesYes           1.9265      0.81618        4.547 0.1345425
## lviYes                   5.3084      2.28796       12.316 0.0001013
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.pos.p50Low         1.3643      0.69482        2.679 0.3668708
## age                      1.0268      0.98491        1.071 0.2129818
## sexMale                  0.9718      0.45924        2.056 0.9404151
## location2Ureter          0.7306      0.36438        1.465 0.3766453
## WHO.gradeLow Grade       0.2721      0.06346        1.167 0.0797038
## lymph.nodesYes           2.0057      0.85221        4.721 0.1109921
## lviYes                   5.1563      2.24173       11.860 0.0001137
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI  P value
## tumor.pos.q3Low          0.6918      0.34043        1.406 0.308396
## age                      1.0266      0.98477        1.070 0.215890
## sexMale                  0.8640      0.40947        1.823 0.701152
## location2Ureter          0.7392      0.36999        1.477 0.391980
## WHO.gradeLow Grade       0.2634      0.06168        1.125 0.071634
## lymph.nodesYes           2.1642      0.89316        5.244 0.087314
## lviYes                   5.0005      2.13858       11.692 0.000204
</code></pre>

<hr/>

<h2>7) Hazard Ratios for Cancer-Specific Mortality</h2>

<h3>7.1) Clinicopathologic features</h3>

<ul>
<li>Patient&#39;s age</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.035        0.992        1.079  0.1125
</code></pre>

<ul>
<li>Patient&#39;s sex</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.332        0.622        2.854  0.4603
</code></pre>

<ul>
<li>Tumor location (Pelvis vs. ureter, tumors in pelvis-ureter excluded)</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.214       0.5824         2.53   0.605
</code></pre>

<ul>
<li>High pT stage (&gt;pT2)</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI   P value
## [1,]        17.63        4.185         74.3 9.198e-05
</code></pre>

<ul>
<li>WHO histologic grade</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.1283      0.01743       0.9449 0.04384
</code></pre>

<ul>
<li>Metastatic lymph nodes</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]         2.76         1.18        6.452 0.01914
</code></pre>

<ul>
<li>Lymphovascular invasion</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI   P value
## [1,]        5.637        2.503        12.69 2.977e-05
</code></pre>

<h3>7.2) ARID1a Unadjusted</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.177       0.3568        3.884  0.7888
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.8791       0.4244        1.821  0.7287
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]       0.7786       0.3745        1.619  0.5026
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.177       0.3568        3.884  0.7888
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        1.454       0.7076        2.987  0.3084
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##      Hazard Ratio Lower 95% CI Upper 95% CI P value
## [1,]        0.851       0.3892        1.861   0.686
</code></pre>

<h3>7.3) ARID1a, Adjusted by Clinicopathologic Features</h3>

<ul>
<li>H-score = 0 vs. H-score &gt; 0</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.h.0Low             1.9287      0.54382        6.840 0.3091992
## age                      1.0397      0.98729        1.095 0.1401229
## sexMale                  0.9341      0.40465        2.156 0.8730789
## location2Ureter          0.8456      0.39361        1.817 0.6673501
## WHO.gradeLow Grade       0.1818      0.02416        1.369 0.0978741
## lymph.nodesYes           0.8948      0.32964        2.429 0.8273925
## lviYes                   5.2952      2.06982       13.547 0.0005055
</code></pre>

<ul>
<li>H-score &lt; median vs. H-score &gt; median</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.h.p50Low           1.2990       0.5820        2.899 0.5230258
## age                      1.0370       0.9853        1.091 0.1640878
## sexMale                  0.9861       0.4098        2.373 0.9751609
## location2Ureter          0.9097       0.4226        1.958 0.8088639
## WHO.gradeLow Grade       0.1757       0.0234        1.320 0.0910324
## lymph.nodesYes           0.9408       0.3496        2.532 0.9038682
## lviYes                   5.0601       2.0194       12.679 0.0005411
</code></pre>

<ul>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.h.q3Low            1.0998      0.49752        2.431 0.8141748
## age                      1.0337      0.98313        1.087 0.1951305
## sexMale                  0.9075      0.39034        2.110 0.8216500
## location2Ureter          0.8831      0.41001        1.902 0.7508958
## WHO.gradeLow Grade       0.1762      0.02344        1.324 0.0916208
## lymph.nodesYes           0.9019      0.33267        2.445 0.8392319
## lviYes                   5.1775      2.05462       13.047 0.0004884
</code></pre>

<ul>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.pos.0Low           1.9287      0.54382        6.840 0.3091992
## age                      1.0397      0.98729        1.095 0.1401229
## sexMale                  0.9341      0.40465        2.156 0.8730789
## location2Ureter          0.8456      0.39361        1.817 0.6673501
## WHO.gradeLow Grade       0.1818      0.02416        1.369 0.0978741
## lymph.nodesYes           0.8948      0.32964        2.429 0.8273925
## lviYes                   5.2952      2.06982       13.547 0.0005055
</code></pre>

<ul>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.pos.p50Low         1.6672      0.75770        3.668 0.2039476
## age                      1.0330      0.98280        1.086 0.2014588
## sexMale                  1.0771      0.45659        2.541 0.8652576
## location2Ureter          0.9522      0.44351        2.044 0.9000090
## WHO.gradeLow Grade       0.1765      0.02336        1.333 0.0927526
## lymph.nodesYes           0.9799      0.36458        2.634 0.9678988
## lviYes                   4.8058      1.94141       11.896 0.0006876
</code></pre>

<ul>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>

<pre><code>##                    Hazard Ratio Lower 95% CI Upper 95% CI   P value
## tumor.pos.q3Low          1.1021      0.46562        2.609 0.8249088
## age                      1.0331      0.98215        1.087 0.2070246
## sexMale                  0.9035      0.39013        2.092 0.8127146
## location2Ureter          0.8760      0.40968        1.873 0.7326664
## WHO.gradeLow Grade       0.1739      0.02319        1.305 0.0888985
## lymph.nodesYes           0.8961      0.32734        2.453 0.8308582
## lviYes                   5.1804      2.05060       13.087 0.0005038
</code></pre>

<hr/>

</body>

</html>

